Randomized, placebo-controlled trial of the angiotensin-converting enzyme inhibitor, ramipril, in patients with coronary or other occlusive arterial disease

Journal of the American College of Cardiology

Volumn 36, Issue 2, 2000, Pages 438-443

  MacMahon, Stephen ^a   Sharpe, Norman ^b   Gamble, Greg ^b   Clague, Alison ^b   Ni Mhurchu, Cliona ^b   Clark, Taane ^b   Hart, Hamish ^c   Scott, John ^b   White, Harvey ^d  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c NORTH SHORE HOSPITAL   (New Zealand)

^d GREEN LANE HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLACEBO; RAMIPRIL;

ADULT; AGED; ARTERY INTIMA; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; B SCAN; BLOOD PRESSURE REGULATION; CAROTID ARTERY OBSTRUCTION; CLINICAL TRIAL; COMMON CAROTID ARTERY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE MASS; HUMAN; M MODE ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THICKNESS; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ARTERIAL OCCLUSIVE DISEASES; CAROTID ARTERY DISEASES; CAROTID ARTERY, COMMON; CORONARY DISEASE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; RAMIPRIL;

EID: 0033860871     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(00)00736-1     Document Type: Article

References (24)

1. Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection
2. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure
3. Cell biology and genetics of angiotensin in cardiovascular disease
4. Antiatherogenic effect of captopril in the watanabe heritable hyperlipidemic rabbit
5. Effects of captopril on atherosclerosis in cynomolgus monkeys
6. Inhibitors of angiotensin converting enzyme prevent myointimal proliferation after vascular injury
7. Effect of perindopril on the development of atherosclerosis in the cholesterol-fed rabbit
8. Effects of lowering average or below average cholesterol levels on the progression of carotid atherosclerosis. Results of the LIPID Atherosclerosis Substudy
9. B-mode ultrasound images of the carotid artery wall: Correlation of ultrasound with histological measurements
10. Angiotensin-converting enzyme inhibition as antiatherosclerotic therapy: No answer yet. Coronary artery disease
11. Effect of high dose angiotensin-converting enzyme inhibition on restenosis: Final results of the MARCATOR Study, a multicenter, double-blind, placebo-controlled trial of cilazapril. The Multicenter Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATOR) Study Group
12. Angiotensin converting enzyme inhibition with fosinopril sodium in the prevention of restenosis after angioplasty
13. Blood pressure, stroke and coronary heart disease. Part 1, prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias
14. Blood pressure and mortality among men with prior myocardial infarction
15. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study
16. Prognostic value of left ventricular mass in uncomplicated acute myocardial infarction and on vessel coronary artery disease
17. Reversal of left ventricular hypertrophy in hypertensive patients: A meta-analysis of 109 treatment studies
18. Reversal of left ventricular hypertrophy in essential hypertension: A meta-analysis of randomized double-blind studies
19. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study
20. Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). A randomized controlled trial
21. The Verapamil in Hypertension and Atherosclerosis Study (VHAS): Results of long-term randomized treatment with either verapamil or chlorthalidone on carotid intima-media thickness